State NM
Clinical Trials in New Mexico
New Mexico is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Mexico and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 55 actively recruiting studies with New Mexico sites out of 55 registered in total. The busiest research areas in New Mexico are Obesity, Acute Myeloid Leukemia, Recurrent Endometrial Carcinoma. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of New Mexico, NRG Oncology. By stage, New Mexico trials break down as Phase 1 (5), Phase 2 (16), Phase 3 (27), Phase 4 (1).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Mexico
Obesity (3)Acute Myeloid Leukemia (2)Recurrent Endometrial Carcinoma (2)Type 2 Diabetes (2)Lung Non-Small Cell Carcinoma (2)Breast Cancer (2)Recurrent Head and Neck Squamous Cell Carcinoma (1)Recurrent Hypopharyngeal Squamous Cell Carcinoma (1)Recurrent Laryngeal Squamous Cell Carcinoma (1)Recurrent Oral Cavity Squamous Cell Carcinoma (1)Recurrent Oropharyngeal Squamous Cell Carcinoma (1)Hematologic Tests (1)
Frequently Asked Questions — Clinical Trials in New Mexico
How many clinical trials are currently recruiting in New Mexico?
ClinicalMetric currently tracks 55 actively recruiting clinical trials with at least one location in New Mexico. The total number of registered studies—including active but not currently enrolling trials—is 55. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Mexico?
New Mexico hosts clinical trials across a broad range of medical conditions, including Obesity, Acute Myeloid Leukemia, Recurrent Endometrial Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Mexico serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Mexico?
To join a clinical trial in New Mexico, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Mexico maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Mexico
NCT05235165 Phase 3
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients ...
Condition
Metastatic Malignant Neoplasm in the Lung
Enrollment
62 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07313319 N/A
Recruiting
Trial of Underwater Birth
Condition
Birth
Enrollment
230 pts
Location
United States
Sponsor
University of New Mexico
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
NCT07213804 Phase 3
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum...
Condition
Ovarian Neoplasms
Enrollment
1,630 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
NCT07290036 Phase 1
Recruiting
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Simila...
Condition
Psoriatic Arthritis
Enrollment
392 pts
Location
United States, Bulgaria, Czechia
Sponsor
UCB Biopharma SRL
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT07062588 Phase 2
Recruiting
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 Ge...
Condition
Osteogenesis Imperfecta (OI)
Enrollment
80 pts
Location
United States, Argentina, Australia
Sponsor
Angitia Incorporated Limited
NCT04772131 N/A
Recruiting
Desara ® One Single Incision Sling 522 Study
Condition
Stress Urinary Incontinence
Enrollment
300 pts
Location
United States
Sponsor
Caldera Medical, Inc.
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
900 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
NCT06877884 N/A
Recruiting
A Prospective Registry to Enable Collection of Standardized Routine Care Oncolog...
Condition
Cancer
Enrollment
20,000 pts
Location
United States
Sponsor
N-Power Medicine
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT00063063 N/A
Recruiting
Generic Database of Very Low Birth Weight Infants
Condition
Infant, Newborn
Enrollment
80,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT06215716 Phase 3
Recruiting
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Stea...
Condition
NASH With Fibrosis
Enrollment
1,650 pts
Location
United States, Argentina, Australia
Sponsor
Akero Therapeutics, Inc
NCT06268704 Phase 4
Recruiting
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
Condition
Sacroiliac Joint Dysfunction
Enrollment
230 pts
Location
United States
Sponsor
University of New Mexico
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT04064359 Phase 1
Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid T...
Condition
Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, France
Sponsor
Oxford BioTherapeutics Ltd
NCT04402788 Phase 2, Phase 3
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment ...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
138 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06997497 Phase 3
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy ...
Condition
Colon Adenocarcinoma
Enrollment
477 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06070350 Phase 3
Recruiting
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage...
Condition
Hemorrhagic Shock
Enrollment
1,000 pts
Location
United States
Sponsor
Philip Spinella
NCT06739122 Phase 3
Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants W...
Condition
Type 2 Diabetes
Enrollment
55 pts
Location
United States, Argentina, Mexico
Sponsor
Eli Lilly and Company
NCT06525220 Phase 3
Recruiting
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in ...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Merus B.V.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology